Combinatorial synthesis of CCR5 antagonists

Area of Science:

• Medicinal Chemistry
• Virology
• Immunology

Background:

• The CCR5 receptor is a key co-receptor for HIV-1 entry into host cells.
• Developing potent CCR5 antagonists is crucial for HIV-1 treatment strategies.
• Structure-Activity Relationship (SAR) studies guide the design of novel antiviral compounds.

Purpose of the Study:

• To prepare a combinatorial library of compounds with high CCR5 binding affinity.
• To discover novel compounds with improved CCR5 antagonist properties.
• To evaluate the anti-HIV-1 activity of identified CCR5 antagonists.

Main Methods:

• Combinatorial chemistry for library synthesis.
• Structure-Activity Relationship (SAR) analysis from traditional medicinal chemistry.
• CCR5 receptor binding assays.
• In vitro anti-HIV-1 activity testing.

Main Results:

• A combinatorial library of compounds with potent CCR5 binding affinity was successfully prepared.
• Novel compounds with unique subunit combinations and high CCR5 receptor affinity were discovered.
• Compound 11, a potent CCR5 antagonist from the library, demonstrated moderate anti-HIV-1 activity.

Conclusions:

• The developed combinatorial library provides a valuable resource for identifying CCR5-targeting agents.
• Compound 11 represents a promising lead candidate for further development as an anti-HIV-1 therapeutic.
• This approach highlights the utility of integrating SAR data with combinatorial chemistry for drug discovery.